Comments on: Bristol-Myers Squibb Establishes Collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) Program in the U.S.

Comments on: Bristol-Myers Squibb Establishes Collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) Program in the U.S. https://www.worldpharmatoday.com/press-releases/bristol-myers-squibb-establishes-collaborative-immuno-oncology-rare-population-malignancy-i-o-rpm-program-in-the-us/ Magazine for the C-level Pharma Executives Fri, 14 Aug 2015 06:49:42 +0000 hourly 1 https://wordpress.org/?v=7.0